Guardion Health Sciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015
Revenue	12.25	11.05	7.23	1.89	0.9	0.94	0.44	0.14	0.11
Revenue Growth (YoY)	10.85%	52.77%	282.74%	109.30%	-4.16%	115.42%	210.11%	25.01%	-
Cost of Revenue	6.85	6.53	4.12	1.95	0.34	0.4	0.18	0.08	0.05
Gross Profit	5.39	4.52	3.11	-0.06	0.56	0.54	0.26	0.07	0.06
Selling, General & Admin	9.19	11.65	13.53	8.9	9.3	6.46	5.28	3.73	5.79
Research & Development	0.15	0.19	0.06	0.16	0.19	0.23	0.26	0.03	0.4
Other Operating Expenses	0.39	10.1	14.26	-0.57	1.56	0	0	0.25	0.26
Operating Expenses	9.73	21.94	27.86	8.49	11.06	6.69	5.54	4.01	6.45
Operating Income	-4.34	-17.42	-24.75	-8.55	-10.5	-6.14	-5.28	-3.95	-6.39
Interest Expense / Income	0	0	0	0.01	0.26	0	0.02	1.1	0.75
Other Expense / Income	-4.49	-2.5	-0	0.01	0.12	1.62	-	0.7	1.7
Pretax Income	0.16	-14.92	-24.75	-8.57	-10.88	-7.77	-5.31	-5.75	-8.84
Net Income	0.16	-14.92	-24.75	-8.57	-10.88	-7.77	-5.31	-5.75	-8.84
Preferred Dividends	0	0.94	0	0	0	0	0.91	0.8	0
Net Income Common	0.16	-15.86	-24.75	-8.57	-10.88	-7.77	-6.22	-6.54	-8.84
Shares Outstanding (Basic)	1	1	0	0	0	0	0	0	0
Shares Outstanding (Diluted)	1	1	0	0	0	0	0	0	0
Shares Change	13.37%	136.61%	66.16%	134.56%	80.63%	44.89%	27.83%	33.00%	-
EPS (Basic)	0.12	-14.15	-52.23	-30.00	-89.50	-114.00	-135.00	-180.00	-324.00
EPS (Diluted)	0.12	-14.15	-52.23	-30.00	-89.50	-114.00	-135.00	-180.00	-324.00
Free Cash Flow	-4.37	-7.45	-10.72	-8.05	-6.2	-4.48	-3.44	-1.66	-1.14
Free Cash Flow Per Share	-3.44	-6.65	-22.63	-28.25	-51.01	-66.63	-74.08	-45.60	-41.80
Gross Margin	44.04%	40.91%	43.00%	-3.01%	62.20%	57.74%	59.88%	46.32%	55.61%
Operating Margin	-35.40%	-157.66%	-342.13%	-452.51%	-1162.53%	-652.09%	-1207.60%	-2797.79%	-5663.22%
Profit Margin	1.29%	-143.57%	-342.11%	-453.56%	-1204.77%	-824.43%	-1421.23%	-4639.77%	-7837.26%
Free Cash Flow Margin	-35.71%	-67.44%	-148.19%	-426.21%	-686.77%	-475.94%	-786.78%	-1174.88%	-1012.24%
EBITDA	0.18	-13.67	-23.96	-8.34	-9.99	-7.47	-5.16	-4.58	-8.03
EBITDA Margin	1.45%	-123.74%	-331.28%	-441.56%	-1106.85%	-792.81%	-1180.44%	-3250.19%	-7122.18%
Depreciation & Amortization	0.02	1.25	0.78	0.22	0.63	0.3	0.12	0.06	0.05
EBIT	0.16	-14.92	-24.75	-8.56	-10.62	-7.77	-5.28	-4.64	-8.09
EBIT Margin	1.29%	-135.05%	-342.11%	-453.18%	-1176.16%	-824.19%	-1207.60%	-3292.83%	-7169.82%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).